Ibrutinib Deacryloylpiperidine CAS 330786-24-8 Ịdị ọcha>99.0% (HPLC)

Nkọwa dị mkpirikpi:

Aha Chemical: Ibrutinib Deacryloylpiperidine

Nọmba: 330786-24-8

Dị ọcha:> 99.0% (HPLC)

Ọdịdị: Gbanyụọ-White na Khaki ntụ ntụ

Ọkara nke Ibrutinib (CAS: 936563-96-1)

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ndị etiti metụtara Ibrutinib:
(S) -1-Boc-3-Hydroxypiperidine CAS 143900-44-1
4-Phenoxyphenylboronic Acid CAS 51067-38-0
Ibrutinib Intermediate N-2 CAS 330786-24-8
Ibrutinib Intermediate N-3 CAS 330792-70-6
Ibrutinib CAS 936563-96-1

Njirimara kemịkalụ:

Aha Chemical	3- (4-Phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-4-amine
Ụdị okwu	Ibrutinib intermeidate N-2;Ibrutinib Deacryloylpiperidine;Ibrutinib adịghị ọcha 8;5- (4-Phenoxyphenyl) -7H-pyrrolo [2,3-d] pyrimidin-4-ylamine;IBT4A;Ibrutinib N-Despiperidinyl adịghị ọcha
Nọmba CAS	330786-24-8
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C17H13N5O
Ibu molekụla	303.32
Ebe Na-agbaze	> 262 ℃ (Dec.)
Njupụta	1.380±0.06 g/cm3
Klas Hazard	6.1;Nsi
Otu nkwakọ ngwaahịa	III
COA & MSDS	Dị
Mmalite	Shanghai, China
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Gbanyụọ-White ka Khaki ntụ ntụ
njirimara	HNMR, LC-MS
Ụzọ ịdị ọcha / nyocha	> 99.0% (HPLC)
Ọnwụ na ihicha	<1.00%
Otu Max.adịghị ọcha	<1.00%
Mgbakọta adịghị ọcha	<1.00%
Ọla dị arọ (dị ka Pb)	<20ppm
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Ibrutinib (CAS: 936563-96-1)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

Ajụjụ:

330786-24-8 - Ngwa:

3- (4-Phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-4-amine (CAS: 330786-24-8) bụ etiti synthetic bara uru na njikọ nke Ibrutinib (CAS: 936563-96-1). ).Ibrutinib bụ ụdị Bruton tyrosine kinase (BTK) inhibitor, enwere ike iji ya maka ọgwụgwọ ọrịa leukemia lymphocytic na-adịghị ala ala (CLL) na lymphoma mantle cell (MCL).MCL na CLL bụ nke B-cell na-abụghị Hodgkin's lymphoma, nke siri ike ịgwọ ma dị mfe ịmaliteghachi.Immunotherapy kemịkalụ a na-ahụkarị enweghị ebumnuche, na-emekarị mmeghachi omume ọjọọ 3 ma ọ bụ 4.Ibrutinib na B lymphocytes nwere ike ilekwasị anya na BTK bụ nke dị mkpa maka nhazi, ọdịiche, na nnyefe ozi, na-egbochi ọrụ BTK na-agbanwe agbanwe, na-egbochi mmụba cell tumor na nlanarị nke ọma.Ibrutinib nwere ike itinye uche ngwa ngwa mgbe nchịkwa ọnụ gasịrị, n'oge 1 ~ 2h ruru oke ntinye ọbara, mmeghachi omume ọjọọ bụ otu ma ọ bụ abụọ, ya mere, Ibrutinib ga-aghọ nhọrọ ọhụrụ nke ọgwụgwọ CLL na MCL.